Cargando…
Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells
Glioblastoma multiforme (GBM) is one of the deadliest cancers of the brain. Its ability to infiltrate healthy brain tissues renders it difficult to remove surgically. Furthermore, it exhibits high rates of radio- and chemoresistance, making the survival rates of patients with GBM poor. Therefore, no...
Autores principales: | Valdez, Laura, Cheng, Benxu, Gonzalez, Daniela, Rodriguez, Reanna, Campano, Paola, Tsin, Andrew, Fang, Xiaoqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084225/ https://www.ncbi.nlm.nih.gov/pubmed/35548329 http://dx.doi.org/10.18632/oncotarget.28227 |
Ejemplares similares
-
Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
por: Cheng, Benxu, et al.
Publicado: (2017) -
Gene expression time-series analysis of Camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines
por: Morandi, Elena, et al.
Publicado: (2008) -
Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line
por: Markiewicz-Żukowska, Renata, et al.
Publicado: (2013) -
Exosome Proteome of U-87MG Glioblastoma Cells
por: Chun, Sohyun, et al.
Publicado: (2016) -
Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR
por: Bassi, Rosaria, et al.
Publicado: (2023)